Induction of antigen-specific cytotoxic T-cell response by dendritic cells generated from ecto-mesenchymal stem cells infected with an adenovirus containing the MAGE-D4a gene

Hu,Shijie; Li,Bing; Shen,Xuefeng; Zhang,Rui; Gao,Dakuan; Guo,Qingdong; Jin,Yan; Fei,Zhou

doi:10.3892/ol.2016.4306

Induction of antigen-specific cytotoxic T-cell response by dendritic cells generated from ecto-mesenchymal stem cells infected with an adenovirus containing the MAGE-D4a gene

Authors:
- Shijie Hu
- Bing Li
- Xuefeng Shen
- Rui Zhang
- Dakuan Gao
- Qingdong Guo
- Yan Jin
- Zhou Fei
View Affiliations

Affiliations: Department of Neurosurgery, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China, Department of Occupational and Environmental Health and The Ministry of Education Key Laboratory of Hazard Assessment and Control in Special Operational Environment, School of Public Health, Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China, Department of Biochemistry and Molecular Biology, Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China, Department of Oral Histology and Pathology, Research and Development Center for Tissue Engineering, School of Stomatology, Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China
Published online on: March 7, 2016 https://doi.org/10.3892/ol.2016.4306
Pages: 2886-2892

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to investigate the feasibility of using ecto-mesenchymal stem cell (EMSC)-derived dendritic cells (DCs) for glioma immunotherapy following infection by a recombinant adenovirus containing the melanoma-associated antigen D4a (MAGE-D4a) gene. The ex vivo cultured EMSCs were infected by the adenoviral plasmid containing MAGE-D4a (pAd/MAGE-D4a). Efficiency of transfection was evaluated through the detection of green fluorescent protein‑marked MAGE‑D4a. The MAGE‑EMSCs were induced to differentiate into DCs, termed as MAGE‑EMSCs-DCs. The morphology was subsequently analyzed under a microscope, and methyl thiazolyl tetrazolium (MTT) and interferon‑γ (IFN‑γ) assays were performed to analyze the cytotoxicity of the MAGE‑EMSC‑DCs on the human glioma U251 cell line. Following purification by magnetic‑activated cell sorting, the EMSCs grew into swirls, with a long spindle shape and were fibroblast‑like. The gene transfected with recombinant adenovirus vectors maintained high and stable expression levels of MAGE‑D4a, and its efficiency was increased in a multiplicity of infection‑dependent manner. The results of the MTT assay indicated that the T cells, primed by the recombinant MAGE‑D4a‑infected EMSC‑DCs in vitro, recognized MAGE‑D4a‑expressing tumor cell lines in a human leukocyte antigen class I‑restricted manner, and evoked a higher cytotoxic T cell (CTL) response. The CTL response induced by the MAGE‑EMSC‑DCs, co‑cultured with the U251 cells for 24 h, produced 765.0 pg/ml IFN‑γ, which was significantly greater when compared to the control wells. T lymphocytes stimulated by MAGE‑EMSC‑DCs evoke a higher CTL response to human glioma cell lines, and may serve as a promising therapeutic modality for the treatment of MAGE‑D4a-expressing glioma.

View Figures

View References

1	Marsh JC, Goldfarb J, Shafman TD and Diaz AZ: Current status of immunotherapy and gene therapy for high-grade gliomas. Cancer Control. 20:43–48. 2013.PubMed/NCBI
2	Chen J and Xu T: Recent therapeutic advances and insights of recurrent glioblastoma multiforme. Front Biosci (Landmark Ed). 18:676–684. 2013. View Article : Google Scholar : PubMed/NCBI
3	Ajeawung NF, Wang HY and Kamnasaran D: Progress from clinical trials and emerging non-conventional therapies for the treatment of Medulloblastomas. Cancer Lett. 330:130–140. 2013. View Article : Google Scholar : PubMed/NCBI
4	Xu Q, Yuan X and Yu JS: Glioma stem cell research for the development of immunotherapy. Adv Exp Med Biol. 746:216–225. 2012. View Article : Google Scholar : PubMed/NCBI
5	Daga A, Bottino C, Castriconi R, Gangemi R and Ferrini S: New perspectives in glioma immunotherapy. Curr Pharm Des. 17:2439–2467. 2011. View Article : Google Scholar : PubMed/NCBI
6	Petrosiute A, Auletta JJ and Lazarus HM: Achieving graft-versus-tumor effect in brain tumor patients: From autologous progenitor cell transplant to active immunotherapy. Immunotherapy. 4:1139–1151. 2012. View Article : Google Scholar : PubMed/NCBI
7	Ardon H, Van Gool SW, Verschuere T, Maes W, Fieuws S, Sciot R, Wilms G, Demaerel P, Goffin J, Van Calenbergh F, et al: Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: Results of the HGG-2006 phase I/II trial. Cancer Immunol Immunother. 61:2033–2044. 2012. View Article : Google Scholar : PubMed/NCBI
8	Prins RM, Wang X, Soto H, Young E, Lisiero DN, Fong B, Everson R, Yong WH, Lai A, Li G, et al: Comparison of glioma-associated antigen peptide-loaded versus autologous tumor lysate-loaded dendritic cell vaccination in malignant glioma patients. J Immunother. 36:152–157. 2013. View Article : Google Scholar : PubMed/NCBI
9	Lasky JL III, Panosyan EH, Plant A, Davidson T, Yong WH, Prins RM, Liau LM and Moore TB: Autologous tumor lysate-pulsed dendritic cell immunotherapy for pediatric patients with newly diagnosed or recurrent high-grade gliomas. Anticancer Res. 33:2047–2056. 2013.PubMed/NCBI
10	Mineharu Y, Muhammad AK, Yagiz K, Candolfi M, Kroeger KM, Xiong W, Puntel M, Liu C, Levy E, Lugo C, et al: Gene therapy-mediated reprogramming tumor infiltrating T cells using IL-2 and inhibiting NF-κB signaling improves the efficacy of immunotherapy in a brain cancer model. Neurotherapeutics. 9:827–843. 2012. View Article : Google Scholar : PubMed/NCBI
11	Tobias A, Ahmed A, Moon KS and Lesniak MS: The art of gene therapy for glioma: A review of the challenging road to the bedside. J Neurol Neurosurg Psychiatry. 84:213–222. 2013. View Article : Google Scholar : PubMed/NCBI
12	Assi H, Candolfi M, Baker G, Mineharu Y, Lowenstein PR and Castro MG: Gene therapy for brain tumors: Basic developments and clinical implementation. Neurosci Lett. 527:71–77. 2012. View Article : Google Scholar : PubMed/NCBI
13	van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, Van den Eynde B, Knuth A and Boon T: A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science. 254:1643–1647. 1991. View Article : Google Scholar : PubMed/NCBI
14	Chomez P, De Backer O, Bertrand M, De Plaen E, Boon T and Lucas S: An overview of the MAGE gene family with the identification of all human members of the family. Cancer Res. 61:5544–5551. 2001.PubMed/NCBI
15	Ito S, Kawano Y, Katakura H, Takenaka K, Adachi M, Sasaki M, Shimizu K, Ikenaka K, Wada H and Tanaka F: Expression of MAGE-D4, a novel MAGE family antigen, is correlated with tumor-cell proliferation of non-small cell lung cancer. Lung Cancer. 51:79–88. 2006. View Article : Google Scholar : PubMed/NCBI
16	Lee MH, Son EI, Kim E, Kim IS, Yim MB and Kim SP: Expression of cancer-testis genes in brain tumors. J Korean Neurosurg Soc. 43:190–193. 2008. View Article : Google Scholar : PubMed/NCBI
17	Leamon JH, Lee WL, Tartaro KR, Lanza JR, Sarkis GJ, deWinter AD, Berka J, Weiner M, Rothberg JM and Lohman KL: A massively parallel PicoTiterPlate based platform for discrete picoliter-scale polymerase chain reactions. Electrophoresis. 25:11762004. View Article : Google Scholar
18	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
19	Zhang X, Zhang W, Mao XG, Zhen HN, Cao WD and Hu SJ: Targeting role of glioma stem cells for glioblastoma multiforme. Curr Med Chem. 20:1974–1984. 2013. View Article : Google Scholar : PubMed/NCBI
20	Reardon DA, Wucherpfennig KW, Freeman G, Wu CJ, Chiocca EA, Wen PY, Curry WT Jr, Mitchell DA, Fecci PE, Sampson JH and Dranoff G: An update on vaccine therapy and other immunotherapeutic approaches for glioblastoma. Expert Rev Vaccines. 12:597–615. 2013. View Article : Google Scholar : PubMed/NCBI
21	Chai Y, Jiang X, Ito Y, Bringas P Jr, Han J, Rowitch DH, Soriano P, McMahon AP and Sucov HM: Fate of the mammalian cranial neural crest during tooth and mandibular morphogenesis. Development. 127:1671–1679. 2000.PubMed/NCBI
22	Hu S, Shen X, Zhang R, Zhang Y, Zhang R, Zhang W, Deng Z, Cao Y, Zhou Z, Chen J, et al: Development of rat antigen-presenting cells from pluripotent ecto-mesenchymal stem cells in vitro and in vivo. Mol Immunol. 45:3818–3826. 2008. View Article : Google Scholar : PubMed/NCBI
23	Syed ON, Mandigo CE, Killory BD, Canoll P and Bruce JN: Cancer-testis and melanocyte-differentiation antigen expression in malignant glioma and meningioma. J Clin Neurosci. 19:1016–1021. 2012. View Article : Google Scholar : PubMed/NCBI
24	Weeraratne SD, Amani V, Neiss A, Teider N, Scott DK, Pomeroy SL and Cho YJ: miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma. Neuro-oncol. 13:165–175. 2011. View Article : Google Scholar : PubMed/NCBI
25	Yang JY, Cao DY, Liu WC, Zhang HM, Teng ZH and Ren J: Dendritic cell generated from CD34+ hematopoietic progenitors can be transfected with adenovirus containing gene of HBsAg and induce antigen-specific cytotoxic T cell responses. Cell Immunol. 240:14–21. 2006. View Article : Google Scholar : PubMed/NCBI
26	Candolfi M, King GD, Yagiz K, Curtin JF, Mineharu Y, Muhammad AK, Foulad D, Kroeger KM, Barnett N, Josien R, et al: Plasmacytoid dendritic cells in the tumor microenvironment: Immune targets for glioma therapeutics. Neoplasia. 14:757–770. 2012. View Article : Google Scholar : PubMed/NCBI
27	Kane A and Yang I: Interferon-gamma in brain tumor immunotherapy. Neurosurg Clin N Am. 21:77–86. 2010. View Article : Google Scholar : PubMed/NCBI
28	Szabo AT and Carpentier AF: Immunotherapy in human glioblastoma. Rev Neurol (Paris). 167:668–672. 2011. View Article : Google Scholar : PubMed/NCBI